Robert Bohnert, APRN
Family · Saint Louis, MONPI 1174293559
Payments from drug & device makers
Across 183 payments — averaging $19.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$621
- Takeda Pharmaceuticals U.S.A., Inc.$366
- Lilly USA, LLC$334
- Amgen$283
- Pfizer$255
- Johnson & Johnson$205
- plus $1K from 31 others
What the payments were for
- Food & beverage$3,503100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $621 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $366 |
| Lilly USA, LLC | 18 | $334 |
| Amgen | 15 | $283 |
| Pfizer | 15 | $255 |
| Johnson & Johnson(2 entities) | 10 | $205 |
| Regeneron Healthcare Solutions, Inc. | 3 | $108 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $105 |
| AstraZeneca(2 entities) | 6 | $98 |
| Sanofi | 2 | $95 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $92 |
| Novartis | 6 | $89 |
| Madrigal Pharmaceuticals | 4 | $74 |
| Novo Nordisk | 3 | $68 |
| Boehringer Ingelheim | 3 | $58 |
| Lundbeck LLC | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 4 | $57 |
| Radius Health, Inc. | 2 | $49 |
| Gilead | 2 | $43 |
| Aimmune Therapeutics, Inc. | 2 | $41 |
| Exact Sciences | 2 | $40 |
| QOL Medical, LLC | 2 | $37 |
| Grifols USA, LLC | 2 | $37 |
| Intercept Pharmaceuticals, Inc. | 2 | $33 |
| Ardelyx, Inc. | 2 | $30 |
| Medtronic | 1 | $29 |
| Braintree Laboratories, Inc. | 1 | $24 |
| Corcept Therapeutics | 1 | $23 |
| Dynavax Technologies Corporation | 1 | $23 |
| Biogen | 1 | $21 |
| Organon | 1 | $19 |
| Philips North America LLC | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Averitas Pharma Inc. | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
How this compares
$3,503 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProliaDenosumab | 44 | $77,704 |
| MounjaroTirzepatide | 28 | $28,803 |
| Repatha SureclickEvolocumab | 28 | $26,769 |
| JardianceEmpagliflozin | 23 | $22,695 |
| OzempicSemaglutide | 18 | $17,609 |
| TrulicityDulaglutide | 12 | $10,352 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $7,762 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 23 | $5,975 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 30 | $4,320 |
| Atorvastatin Calcium | 231 | $1,527 |
| Omeprazole | 78 | $1,105 |
| SynthroidLevothyroxine Sodium | 14 | $972 |
| Famotidine | 53 | $912 |
| Ezetimibe | 37 | $667 |
| Fluticasone Propionate | 34 | $661 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenProlia | $283 | $77,70444 claims |
| Lilly USA, LLCMounjaro, Trulicity | $334 | $39,15540 claims |
| Boehringer IngelheimJardiance | $58 | $22,69523 claims |
| Novo NordiskOzempic | $68 | $17,60918 claims |
| AbbVieSynthroid | $621 | $97214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,812 family providers in Missouri.
Other family in Saint Louis
- Rebecca SeabaughSaint Louis$68K
- Jordan PerezSaint Louis$43K
- Lindsay GwaltneySaint Louis$28K
- Sara WoottenSaint Louis$21K
- Kelly RobertsSaint Louis$17K
- Matthew CarySaint Louis$15K
- Philip DudakSaint Louis$14K
- Kenan SahbazSaint Louis$14K
- Nicole CarrSaint Louis$14K
- Ashley GarrettSaint Louis$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.